Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eighteen research firms that are currently covering the company ...

Park Avenue Securities LLC boosted its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 34.5% in the 4th ...

Closed loop insulin pump therapy lowers the risk for hypoglycemic coma but increases diabetic ketoacidosis risk among patients with T1D.

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

TNDM's shares rise as its expanding product portfolio gains market traction. However, the unfavorable macroeconomic scenario ...

The renowned medical device company has a market capitalization of $2.31 billion. Tandem Diabetes projects a growth rate of 28.6% for 2025 earnings compared with 18.7% for the S&P 500. TNDM delivered ...

CHICAGO, NY, UNITED STATES, January 17, 2025 /EINPresswire / -- The global insulin pump <a target=_blank href= ...

While this option may be less expensive and seems convenient, it’s best to consult a doctor about dosage if you use it, says Joshua J. Neumiller, CDCES, PharmD, the president elect of ...

Even though pump therapy may increase the costs associated ... although it may provide a more precise tool for insulin therapy, avoiding frequent injections in very young children.

The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is ...